Carregant...
A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy
Breast cancer remains a significant cause of death in women and few therapeutic options exist for estrogen receptor negative ER(−) cancers. Epigenetic re-activation of target genes using histone deacetylase (HDAC) inhibitors has been proposed in ER(−) cancers to resensitize to therapy using selectiv...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3962780/ https://ncbi.nlm.nih.gov/pubmed/23956109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201300270 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|